ADAG
Adagene Inc. American Depositary Shares
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.950
Máximo
$1.950
Mínimo
$1.950
Volume
0.00M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
Adagene to Present at Jefferies Global Healthcare Conference 2025
SAN DIEGO and SUZHOU, China, May 27, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events In combination with pembrolizumab, ADG126 showed a 29% confirmed overall response rate (ORR)
Ações relacionadas
AUTL
Autolus Therapeutics plc American Depositary Share
LOBO
LOBO EV TECHNOLOGIES LTD. Ordinary shares
WB
Weibo Corporation American Depositary Share
LUNA
Luna Innovations Incorporated
RDNT
RadNet Inc.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.